Results 181 to 190 of about 665,294 (217)

The role of exercise in aromatase inhibitor-induced arthralgia. [PDF]

PM R
Yu K, Portes P, Morris GS, Huang L, Felix ER, Farkas GJ, Molinares D, Tiozzo E.   +7 more
europepmc   +1 more source

Changes in LDL-cholesterol levels following aromatase inhibitor treatment in early postmenopausal breast cancer. [PDF]

Eur J Epidemiol
Lund M, Corn G, Jensen MB, Petersen T, Dalhoff K, Ejlertsen B, Køber L, Wohlfahrt J, Melbye M.   +8 more
europepmc   +1 more source

OATP1B-type Transport Function Is a Determinant of Aromatase Inhibitor-Associated Arthralgia Susceptibility. [PDF]

Cancer Res Commun
Taheri H, Li Y, Huang KM, Ahmed E, Jin Y, Drabison T, Yang Y, Kulp SK, Young NA, Li J, Cheng X, Corps KN, Coss CC, Vaughn JE, Lustberg MB, Sparreboom A, Hu S.   +16 more
europepmc   +1 more source

Aromatase Inhibitor Monotherapy to Augment Height in Boys: Does It Work and Is It Safe? [PDF]

J Endocr Soc
Geffner ME.
europepmc   +1 more source

24-week home-based walking program in the early adjuvant setting in breast cancer patients who receive aromatase inhibitor endocrine therapy: lessons learned from the SAKK 95/17 WISE prospective, randomized, multicenter trial. [PDF]

Breast
Güth U, Hoefnagels N, Müller A, Schär S, Rosset L, Nobahar Corke M, Schwitter M, Jakob A, Balmelli C, Leo C, Fehr M, Thorn DR, Riniker S, Chouiter-Djebaili A, Musilova J, Ribi K, Honecker F, Swiss Cancer Institute.   +17 more
europepmc   +1 more source

Role function in postmenopausal women during aromatase inhibitor therapy for breast cancer. [PDF]

J Cancer Surviv
Melnyk H, Dickson VV, Bender C, Yu G, Djukic M, Merriman J.   +5 more
europepmc   +1 more source

Red Wine as an Aromatase Inhibitor: A Narrative Review. [PDF]

Cureus
Pergolizzi J, LeQuang JAK, Wagner M, Salah R, Magnusson P, Varrassi G.   +5 more
europepmc   +1 more source

Matching-adjusted indirect comparison of ribociclib + nonsteroidal aromatase inhibitor versus abemaciclib + endocrine therapy in hormone receptor-positive/HER2-negative early breast cancer. [PDF]

J Comp Eff Res
Chia S, Li J, Ma F, Stellato D, Danyliv A, Ferrusi I, Hu H, Akdere M, Makris A.   +8 more
europepmc   +1 more source

Real-world clinical outcomes associated with first-line palbociclib and aromatase inhibitor therapy among patients with HR+/HER2- advanced breast cancer in Europe. [PDF]

Breast Cancer Res Treat
Oikonomidou O, Beresford MJ, Galve-Calvo E, Woeckel A, Parikh RC, Hitchens A, Chen C, Doan J, Li B, Ansquer VD, Frugier G, Jimenez MI, Davis KL, Broughton EI.   +13 more
europepmc   +1 more source

Adult Height Following Prepubertal Treatment With Antiandrogen, Aromatase Inhibitor, and Reduced Hydrocortisone in CAH.

J Clin Endocrinol Metab
Merke DP, Mallappa A, Parker M, Sukin C, Kulkarni SE, Keil MF, Van Ryzin C, Hill SC, Reynolds JC, Cutler GB, Sinaii N.   +10 more
europepmc   +1 more source